FCA
CMD

FinTrust Capital Advisors’s Cantel Medical Corporation CMD Stock Holding History

FinTrust Capital Advisors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,360
Closed -$109K – 1235
2021
Q1 		$109K Sell
1,360
-567
-29% -$44.3K 0.03% 396
2020
Q4 		$152K Sell
1,927
-10
-0.5% -$586 0.05% 297
2020
Q3 		$85 Buy
1,937
+243
+14% +$12K 0.02% 390
2020
Q2 		$75K Buy
1,694
+1,630
+2,547% +$60.8K 0.03% 403
2020
Q1 		$2K Hold
64
– – ﹤0.01% 1044
2019
Q4 		$5K Buy
64
+18
+39% +$1.31K ﹤0.01% 879
2019
Q3 		$3K Buy
46
+16
+53% +$1.36K ﹤0.01% 966
2019
Q2 		$2K Hold
30
– – ﹤0.01% 983
2019
Q1 		$2K Sell
30
-9
-23% -$682 ﹤0.01% 1153
2018
Q4 		$3K Buy
+39
New +$3.22K ﹤0.01% 1071

FinTrust Capital Advisors's CMD Position: Q2 2021 in Review

FinTrust Capital Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 1,360 shares — an estimated $109K sold.

FinTrust Capital Advisors first reported a position in CMD in Q4 2018 and held it in 10 quarters. The position peaked at $152K in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • FinTrust Capital Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • FinTrust Capital Advisors sold 1,360 Cantel Medical Corporation shares in Q2 2021, an estimated $109K.
  • FinTrust Capital Advisors first reported a position in Cantel Medical Corporation in Q4 2018 and held it in 10 quarters.
  • FinTrust Capital Advisors's Cantel Medical Corporation position peaked at $152K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on FinTrust Capital Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.